Model N's 2024 Report: Manufacturing Priorities & Challenges

Share
Challenges for Pharmaceutical Manufacturers Revealed in new Report from Model N
Gloria Kee, Product Management at Model N, discusses the results of Model N's 2024 State of Revenue Report & what they mean for high-tech & pharma

Model N, Inc. has today released its sixth annual State of Revenue Report, revealing executives’ top business priorities - and their biggest challenges. 

Based in San Mateo, California, Model N was founded in 1999 and is a leader in revenue optimisation and compliance for high-tech innovators, as well as in the pharma sector. Its intelligent platform powers digital transformation by using integrated technology, data, analytics and expert services.

Its 2024 report identifies process efficiency and cost-saving measures as the greatest priorities for executives, with stronger emphasis put on advanced analytics and AI. Unsurprisingly, supply chain disruption is one of the biggest obstacles to innovation. 

 

Challenges for pharmaceutical manufacturers 

The 2024 survey results examined industry-specific challenges, showing that pharmaceutical manufacturing executives are worried about the influence of regulations on future revenue. 

Execs from the US said that they are preparing for a ‘significant revenue impact’ from the price negotiations with Medicare under the Inflation Reduction Act, twice the amount from the 2023 survey.

94% of pharmaceutical executives said that they were experiencing challenges with formulary validation, a verification process which proves that payers are meeting contractual agreements. 

The execs surveyed also said that the top challenges to assuring compliance were: 

  • Manual audits (49%) 
  • Limited access to formulary data (48%).

 

Report shows high-tech manufacturers embrace AI and RPA amidst supply chain challenges

Gloria Kee, Vice President, Product Management at Model N, says that these insights from Model N’s 2024 State of Revenue Report, reveal high-tech manufacturers are actively responding to shifting market dynamics. 

“With ongoing supply chain disruptions and component inventories piling up, nearly 60% of executives stated that they will ramp up investments in artificial intelligence to optimise revenue operations, and nearly half will do the same in robotic process automation,” says Kee. “The survey also uncovered opportunities such as sharing pricing information for industry benchmarking purposes and utilising channel sales data for more informed pricing adjustments. With only 27% of companies leveraging channel data today, most are missing out on key information to optimise price points in markets worldwide. As economic uncertainty persists, channel insights are a largely untapped resource to help manufacturers make more data-driven decisions.”
 

****** 

Make sure you check out the latest edition of Manufacturing Digital and also sign up to our global conference series - Procurement & Supply Chain 2024 & Sustainability LIVE 2024
******
Manufacturing Digital is a BizClik brand.

Share

Featured Articles

Tata & JLR: Supercharging Next Gen Automotive Connectivity

With the Tata Communications MOVE platform, JLR is ensuring electric fleet connectivity, driving the future of software-defined automotive manufacturing

FUJIFILM Diosynth Biotechnologies Expands in Denmark

The life science company FUJIFILM Diosynth Biotechnologies is investing in its Hillerød site to drive the development & advancement of Danish life science

Reviewing Trump's First Term to Prepare for the Second

With Donald Trump returning to the White House, we reflect on the impact of the manufacturing policies, rules and tariffs imposed during his first term

Amazon Delivers One Billion Packages via Electric Vehicle

Sustainability & ESG

Rolls-Royce Invests Millions to Expand Goodwood Facility

Production & Operations

Manufacturing Unwrapped: Manufacturing Leader Jeff Winter

Digital Factory